Kroeger Christopher A.

Chief Executive Officer, DirectorMapLight Therapeutics, Inc. (MPLT) · full profile →Form 4 · filed Jul 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.4M
Net Open-Market Flow
-$5.4M
Transactions
7
7 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 17, 2026Sell(S)17K$37.90$636K1.2M
Jul 16, 2026Sell(S)41K$36.46$1.5M1.3M
Jul 16, 2026Sell(S)28K$37.26$1.0M1.3M
Jul 16, 2026Sell(S)92$37.96$3K1.3M
Jul 15, 2026Sell(S)43K$36.99$1.6M1.3M
Jul 15, 2026Sell(S)90$37.54$3K1.3M
Jul 15, 2026Sell(S)19K$36.00$682K1.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001658918-26-000014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about MPLT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001658918-26-000014"
Ask your agent
Use Arkolith to summarize insider buying and selling at MapLight Therapeutics, Inc.
over the last 90 days and cite the filings.